suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE)

Conditions:   COVID-19;   Virus Diseases;   Corona Virus Infection;   LRTI;   Lower Respiratory Tract Infection Viral Interventions:   Drug: Anakinra;   Drug: trimethoprim/sulfamethoxazole Sponsor:   Hellenic Institute for the Study of Sepsis Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials